Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy for human malignant melanoma.

A W Kopf

    Southern Medical Journal
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Immunotherapy shows promise for malignant melanoma by harnessing the body's immune responses. While not uniformly successful, these approaches offer encouraging results for treating this aggressive cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of dermoscopy and digital imaging in the diagnosis of cutaneous malignant melanoma.

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
    Same author

    Can early malignant melanoma be differentiated from atypical melanocytic nevi by in vivo techniques?: Part I. Clinical and dermoscopic characteristics.

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
    Same author

    Can early malignant melanoma be differentiated from atypical melanocytic nevus by in vivo techniques?: Part II. Automatic machine vision classification.

    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
    Same author

    Early death from clinical stage I melanoma.

    The Journal of investigative dermatology·2010
    Same author

    Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.

    The Journal of investigative dermatology·2010
    Same author

    The significance of multiple blue-grey dots (granularity) for the dermoscopic diagnosis of melanoma.

    The British journal of dermatology·2007
    Same journal

    SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

    Southern medical journal·2026
    Same journal

    Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

    Southern medical journal·2026
    Same journal

    Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

    Southern medical journal·2026
    Same journal

    Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

    Southern medical journal·2026
    Same journal

    Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

    Southern medical journal·2026
    Same journal

    Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Malignant melanoma triggers humoral and cell-mediated immune responses in humans.
    • Immunotherapy aims to leverage these natural responses for cancer treatment.

    Purpose of the Study:

    • To review the status of immunotherapy for human malignant melanoma up to 1972.
    • To evaluate the feasibility and efficacy of different immunotherapeutic strategies.

    Main Methods:

    • Review of specific immunotherapy using tumor antigen, antimelanoma lymphocytes, or antibodies.
    • Review of nonspecific immunotherapy employing unrelated antigens like BCG or smallpox vaccine to stimulate an immune response.

    Main Results:

    • Several promising immunotherapy approaches for malignant melanoma have been identified.

    Related Experiment Videos

  • Testimonials suggest potential efficacy, but results are not consistently successful.

    • Conclusions:

    • Immunotherapy for malignant melanoma is feasible.
    • Encouraging, though not uniformly successful, results warrant continued investigation and development of immunotherapeutic strategies for this cancer.